Denali Therapeutics (DNLI) Investor Presentation - Slideshow

Disclaimers BUILDING DENALI TO DEFEAT DEGENERATION Discovery engine with >14 programs in discovery stage, 20+ publications in toptier journals, and 90+ patents granted WW Complete 3 - 4 late-stage clinical studies and establish commercial launch readiness Defeating Degeneration Partner of choice in neurodegeneration OUR FOCUS AND STRATEGIC PRINCIPLES 4 Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys c CellPress TREM2 Regulates Microglial ...